Skip to main content
. Author manuscript; available in PMC: 2020 Sep 12.
Published before final editing as: Cancer. 2019 Mar 12:10.1002/cncr.32056. doi: 10.1002/cncr.32056

Table 3.

Risk scoring of IPSS-R, ACE-27, and TP53 (I-RAT) models.

0 1 1.5 2 3 4
Cytogenetics Very Good Good Intermediate Poor Very Poor
BM blasts <=2 >2-<5% 5–10% >10%
Hemoglobin >=10 8-<10 <8
Platelets >=100 50–100 <50
TP53 mutation No Yes
ACE-27 None Mild Moderate Severe